BIZ NEWS: Can Novartis Convince Insurers a $2.1 Million Gene Therapy Is a Great Deal? - BUSINESS DAILY

Hot

Post Top Ad

Your Ad Spot

Sunday, 26 May 2019

BIZ NEWS: Can Novartis Convince Insurers a $2.1 Million Gene Therapy Is a Great Deal?


Can Novartis Convince Insurers a $2.1 Million Gene Therapy Is a Great Deal?



Getting end payers on board with a seven-figure price for Zolgensma won't be easy.

via FOX BUSINESS NEWS https://fxn.ws/2JG0JFN

No comments:

Post a Comment

Post Top Ad